Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer
Oncolytics Biotech® Will Present REO 033 Trial in Progress Abstract at ESMO 2026 Showcasing Pelareorep’s Potential in Colorectal Cancer
Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.comSummary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.